IMN || Oncology

Goserelin improves fertility in HR-negative breast cancer

Posted on: 02/06/2014 - 15:45

CHICAGO – Use of the gonadotropin-releasing hormone agonist goserelin during chemotherapy for early hormone receptor–negative breast cancer was associated with lower rates of ovarian failure and more...

Field of Interest: Pulmonology

Type: News Item

Goserelin improves fertility in HR-negative breast cancer

Posted on: 02/06/2014 - 15:45

Field of Interest: Oncology

Type: News Item

VIDEO: Goserelin helps dodge ovarian failure in ER-breast cancer

Posted on: 30/05/2014 - 22:50

CHICAGO – Adding the gonadotropin-releasing hormone agonist goserelin (Zoladex) to adjuvant or neoadjuvant chemotherapy boosted fertility prospects in premenopausal women with early-stage...

Field of Interest: Oncology

Type: News Item

VIDEO: Goserelin helps dodge ovarian failure in ER-breast cancer

Posted on: 30/05/2014 - 22:50

CHICAGO – Adding the gonadotropin-releasing hormone agonist goserelin (Zoladex) to adjuvant or neoadjuvant chemotherapy boosted fertility prospects in premenopausal women with early-stage...

Field of Interest: Pulmonology

Type: News Item

Liver cancer without cirrhosis surprisingly common: Is NAFLD the cause?

Posted on: 30/05/2014 - 17:15

CHICAGO – A full 13% of patients diagnosed with hepatocellular carcinoma did not have underlying cirrhosis in a national sample of 1,500 veterans. Although hepatocellular carcinoma (HCC) in patients...

Field of Interest: Gastroentero...

Type: News Item

Liver cancer without cirrhosis surprisingly common: Is NAFLD the cause?

Posted on: 30/05/2014 - 17:15

Field of Interest: Oncology

Type: News Item

Laparoscopic surgery cut length of hospital stay in colorectal cancer

Posted on: 21/05/2014 - 20:35

In patients with colorectal cancer, laparoscopic resection reduced total hospital stay by a median of 2 days, compared with open surgery, researchers reported online May 5 in the Journal of Clinical...

Field of Interest: Oncology

Type: News Item

Watch for the skin side effects of novel melanoma therapies

Posted on: 21/05/2014 - 18:15

WAIKOLOA, HAWAII – The spectacular developments in the treatment of advanced melanoma that began with approval of ipilimumab in 2011 continue to accelerate, and these advances promise to keep...

Field of Interest: Oncology

Type: News Item

Watch for the skin side effects of novel melanoma therapies

Posted on: 21/05/2014 - 18:15

WAIKOLOA, HAWAII – The spectacular developments in the treatment of advanced melanoma that began with approval of ipilimumab in 2011 continue to accelerate, and these advances promise to keep...

Field of Interest: Dermatology

Type: News Item

Clinical data support earlier PSA testing in black men

Posted on: 21/05/2014 - 14:30

ORLANDO – Tumors detected following prostate-specific antigen screening in black men aged 40-54 years had more favorable clinico-pathologic characteristics than those detected in black men aged 55-70...

Field of Interest: Oncology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters